Terms: = Endocrine gland cancer AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884
197 results:
1. Single-cell and transcriptomic analyses reveal the influence of diabetes on ovarian cancer.
Zhao Z; Wang Q; Zhao F; Ma J; Sui X; Choe HC; Chen P; Gao X; Zhang L
BMC Genomics; 2024 Jan; 25(1):1. PubMed ID: 38166541
[TBL] [Abstract] [Full Text] [Related]
2. Single-cell RNA-seq analyses inform necroptosis-associated myeloid lineages influence the immune landscape of pancreas cancer.
Dong W; Zhao H; Xiao S; Zheng L; Fan T; Wang L; Zhang H; Hu Y; Yang J; Wang T; Xiao W
Front Immunol; 2023; 14():1263633. PubMed ID: 38149248
[TBL] [Abstract] [Full Text] [Related]
3. Rational Combinations of PARP Inhibitors with HRD-Inducing Molecularly Targeted Agents.
Lee EK; Liu JF
Cancer Treat Res; 2023; 186():171-188. PubMed ID: 37978136
[TBL] [Abstract] [Full Text] [Related]
4. Combination therapy of tyrosine kinase inhibitor sorafenib with the hsp90 inhibitor onalespib as a novel treatment regimen for thyroid cancer.
Mortensen ACL; Berglund H; Hariri M; Papalanis E; Malmberg C; Spiegelberg D
Sci Rep; 2023 Oct; 13(1):16844. PubMed ID: 37803074
[TBL] [Abstract] [Full Text] [Related]
5. Exploring dual effects of dinutuximab beta on cell death and proliferation of insulinoma.
Karatug Kacar A
Chem Biol Drug Des; 2024 Jan; 103(1):e14368. PubMed ID: 37802653
[TBL] [Abstract] [Full Text] [Related]
6. The therapeutic effects of exosomes the first time isolated from pancreatic islet-derived progenitor cells in the treatment of pancreatic cancer.
Hasoglu I; Karatug Kacar A
Protoplasma; 2024 Mar; 261(2):281-291. PubMed ID: 37798610
[TBL] [Abstract] [Full Text] [Related]
7. Promising targetable biomarkers in pancreatic neuroendocrine tumours.
Borghesani M; Gervaso L; Cella CA; Benini L; Ciardiello D; Algeri L; Ferrero A; Valenza C; Guidi L; Zampino MG; Spada F; Fazio N
Expert Rev Endocrinol Metab; 2023; 18(5):387-398. PubMed ID: 37743651
[TBL] [Abstract] [Full Text] [Related]
8. Integrated transcriptome and proteome analysis indicates potential biomarkers of prostate cancer in offspring of pregnant rats exposed to a phthalate mixture during gestation and lactation.
Aquino AM; Alonso-Costa LG; Santos SAA; Rocha VA; Barbisan LF; Bedrat A; Justulin LA; Flaws JA; Lemos B; Scarano WR
Chemosphere; 2023 Nov; 341():140020. PubMed ID: 37690569
[TBL] [Abstract] [Full Text] [Related]
9. Resistance to Gemcitabine in Pancreatic cancer Is Connected to Methylglyoxal Stress and Heat Shock Response.
Crake R; Gasmi I; Dehaye J; Lardinois F; Peiffer R; Maloujahmoum N; Agirman F; Koopmansch B; D'Haene N; Azurmendi Senar O; Arsenijevic T; Lambert F; Peulen O; Van Laethem JL; Bellahcène A
Cells; 2023 May; 12(10):. PubMed ID: 37408249
[TBL] [Abstract] [Full Text] [Related]
10. hsp90 is a potential risk factor for ovarian cancer prognosis: an evidence of a Chinese clinical center.
Duan C; Li K; Pan X; Wei Z; Xiao L
BMC Cancer; 2023 May; 23(1):489. PubMed ID: 37259027
[TBL] [Abstract] [Full Text] [Related]
11. Mass Spectrometry-Based Proteomics of Epithelial Ovarian cancers: A Clinical Perspective.
Qian L; Sun R; Xue Z; Guo T
Mol Cell Proteomics; 2023 Jul; 22(7):100578. PubMed ID: 37209814
[TBL] [Abstract] [Full Text] [Related]
12. Identification of a New m6A Regulator-Related Methylation Signature for Predicting the Prognosis and Immune Microenvironment of Patients with Pancreatic cancer.
Zou T; Shi D; Wang W; Chen G; Zhang X; Tian Y; Gong P
Mediators Inflamm; 2023; 2023():5565054. PubMed ID: 37181810
[TBL] [Abstract] [Full Text] [Related]
13. hsp90aB1 as the Druggable Target of Maggot Extract Reverses Cisplatin Resistance in Ovarian cancer.
Wang D; Tang X; Ruan J; Zhu Z; Wang R; Weng Y; Zhang Y; Wang T; Huang Y; Wang H; Su Z; Wu X; Tao G; Wang Y
Oxid Med Cell Longev; 2023; 2023():9335440. PubMed ID: 37180757
[TBL] [Abstract] [Full Text] [Related]
14. Precise pancreatic cancer therapy through targeted degradation of mutant p53 protein by cerium oxide nanoparticles.
Zhang H; Zhang W; Hu B; Qin X; Yi T; Ye Y; Huang X; Song Y; Yang Z; Qian J; Zhang Y
J Nanobiotechnology; 2023 Apr; 21(1):117. PubMed ID: 37005668
[TBL] [Abstract] [Full Text] [Related]
15. New Insights into the Biological Response Triggered by Dextran-Coated Maghemite Nanoparticles in Pancreatic cancer Cells and Their Potential for Theranostic Applications.
Balas M; Predoi D; Burtea C; Dinischiotu A
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834718
[TBL] [Abstract] [Full Text] [Related]
16. Silibinin, an hsp90 Inhibitor, on Human ACTH-Secreting Adenomas.
Pecori Giraldi F; Cassarino MF; Sesta A; Lasio G; Losa M
Neuroendocrinology; 2023; 113(6):606-614. PubMed ID: 36791678
[TBL] [Abstract] [Full Text] [Related]
17. Exploring the Antiovarian cancer Mechanisms of Salvia Miltiorrhiza Bunge by Network Pharmacological Analysis and Molecular Docking.
Xu X; Zhang Z; Liu L; Che C; Li W
Comput Math Methods Med; 2022; 2022():7895246. PubMed ID: 36483919
[TBL] [Abstract] [Full Text] [Related]
18. Patient-Derived Pancreatic cancer Cells Induce C2C12 Myotube Atrophy by Releasing Hsp70 and hsp90.
Wu HY; Trevino JG; Fang BL; Riner AN; Vudatha V; Zhang GH; Li YP
Cells; 2022 Sep; 11(17):. PubMed ID: 36078164
[TBL] [Abstract] [Full Text] [Related]
19. Single-Cell Dissection of the Multiomic Landscape of High-Grade Serous Ovarian cancer.
Wang Y; Xie H; Chang X; Hu W; Li M; Li Y; Liu H; Cheng H; Wang S; Zhou L; Shen D; Dou S; Ma R; Mao Y; Zhu H; Zhang X; Zheng Y; Ye X; Wen L; Kee K; Cui H; Tang F
Cancer Res; 2022 Nov; 82(21):3903-3916. PubMed ID: 35969151
[TBL] [Abstract] [Full Text] [Related]
20. Role of surgery to the primary tumor in metastatic anaplastic thyroid carcinoma: pooled analysis and SEER-based study.
Oliinyk D; Augustin T; Rauch J; Koehler VF; Belka C; Spitzweg C; Käsmann L
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3527-3547. PubMed ID: 35960373
[TBL] [Abstract] [Full Text] [Related]
[Next]
